Unusual activity: bulls target XRT & Allergan

In a web exclusive, "Halftime Report" experts Jon and Pete Najarian explain the unusual activity that prompted them to pick up shares of one popular retail ETF, and one big pharma company.

Jon Najarian owns XRT calls. Pete Najarian owns Allergan calls.